Ethyl 2-Chloroacetoacetate CAS 609-15-4 Purity >99.0% (GC) Febuxostat Intermediate Factory

Short Description:

Chemical Name: Ethyl 2-Chloroacetoacetate

CAS: 609-15-4

Purity: >99.0% (GC)

Appearance: Colorless to Light Yellow Clear Liquid

Intermediate of Febuxostat (CAS: 144060-53-7)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Ruifu Chemical Supply Febuxostat Related Intermediates:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS 25984-63-8
Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-01-2
Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-03-4
Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5

Chemical Properties:

Chemical Name	Ethyl 2-Chloroacetoacetate
Synonyms	2-Chloroacetoacetic Acid Ethyl Ester; Ethyl 2-Chloro-3-Oxobutyrate
CAS Number	609-15-4
CAT Number	RF-PI1854
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C6H9ClO3
Molecular Weight	164.59
Melting Point	-80℃
Boiling Point	107℃/14 mmHg (lit.)
Density	1.19 g/mL at 25℃(lit.)
Refractive Index	n20/D 1.441 (lit.)
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	Colorless to Light Yellow Clear Liquid
Purity / Analysis Method	>99.0% (GC)
1 H NMR Spectrum	Consistent With Structure
Total Impurities	<1.00%
Test Standard	Enterprise Standard
Usage	Intermediate of Febuxostat (CAS: 144060-53-7)

Package & Storage:

Package: Fluorinated Bottle, 25kg/Barrel, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture

Advantages:

FAQ:

Application:

Ethyl 2-Chloroacetoacetate (CAS: 609-15-4) is an important intermediate of Febuxostat (CAS: 144060-53-7). Febuxostat is a xanthine oxidase inhibitor, clinically used to treat hyperuricemia (gout). It is a new and highly effective selective inhibitor of non-purine xanthine oxidase. Xanthine oxidase is the key enzyme to promote uric acid production. Febuxosutan can reduce the uric acid level in the blood of patients with hyperuricemia and gout. Clinical studies have shown that the drug is safe and effective. The drug is metabolized through the liver and does not rely on renal excretion.